Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-042323
Filing Date
2012-07-26
Accepted
2012-07-26 17:46:49
Documents
1
Period of Report
2012-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd351701.html 4  
1 FORM 4 rrd351701.xml 4 7561
  Complete submission text file 0001181431-12-042323.txt   8987
Mailing Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760
Business Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760 973-993-4867
Durata Therapeutics, Inc. (Issuer) CIK: 0001544116 (see all company filings)

EIN.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR MORRISTOWN NJ 07960
Business Address
Fishman Corey N. (Reporting) CIK: 0001553594 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35599 | Film No.: 12988323